Cite
HARVARD Citation
Joustra, V. et al. (n.d.). OP03 Highly stable epigenome-wide peripheral blood DNA methylation signatures accurately predict endoscopic response to adalimumab, vedolizumab and ustekinumab in Crohn's disease patients: The EPIC-CD study. Journal of Crohn's and colitis. pp. i6-i8. [Online].